Intercure Ltd. — Regulatory Filings 2025

Nov 25, 2025

6-K 1 form6-k.htm 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of November 2025

Commission File Number: 001-40614

INTERCURE LTD.

(Translation of registrant’s name into English)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1; Options: NewSection

Field: /Page

On November 25, 2025, InterCure Ltd. (the “Company”) announced that it will hold its Annual General Meeting of Shareholders (the “Meeting”) on December 30, 2025 at 4:00 p.m. (Israel time) at the offices of the Company’s attorneys, Amit, Pollak, Matalon & Co., at APM House, 18 Raoul Wallenberg St., Building D, 6 th floor, Ramat Hachayal, Tel Aviv, Israel. In connection with the Meeting, the Company furnishes the following documents:

| 1. | A
copy of the Notice and Proxy Statement with respect to the Meeting describing the proposals
to be voted upon at the Meeting, the procedure for voting in person or by proxy at the Meeting
and various other details related to the Meeting, attached hereto as Exhibit 99.1; and |
| --- | --- |
| 2. | A
form of Proxy Card whereby holders of ordinary shares of the Company may vote at the Meeting
without attending in person, attached hereto as Exhibit 99.2. |

| Exhibit
No. | |
| --- | --- |
| 99.1 | Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders. |
| 99.2 | Proxy Card for holders of ordinary shares with respect to the Company’s Annual General Meeting of Shareholders. |

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| | INTERCURE
LTD. |
| --- | --- |
| Date:
November 25, 2025 | /s/
Amos Cohen |
| | Amos
Cohen |
| | Chief
Financial Officer |

Field: Page; Sequence: 3; Options: Last

Field: /Page